Danone Strengthens Gut Health Portfolio with Akkermansia Acquisition

Deal News | Jun 25, 2025 | Globenewswire

In a strategic move to deepen its investment in gut health and biotic research, Danone has announced the acquisition of The Akkermansia Company (TAC), a Belgian firm with nearly two decades of expertise in biotics. TAC is renowned for its development of the biotic strain Akkermansia muciniphila MucT, which has been clinically proven to enhance the gut barrier, reduce inflammation, and aid in the management of metabolic disorders such as obesity and diabetes. This acquisition aligns with Danone’s Renew strategy, aimed at promoting innovation, science, and consumer health interests in light of the growing demand for healthier products. Danone, a global leader in food and beverages with a diverse portfolio and sales of 27.4 billion in 2024, continues to champion health-focused growth. With a mission to bring health through food, Danone's brands span essential dairy, plant-based products, waters, and specialized nutrition. As an entity present on multiple sustainability indexes, Danone is also pursuing B Corp certification by 2025.

Sectors

Food and Beverage
Biotechnology

Geography

Belgium – Location of The Akkermansia Company, which was acquired by Danone, indicating where part of the company's operations and research facilities are based.
France – Danone, the acquiring company, is headquartered in France, making it a significant geography for understanding the business context.

Industry

Food and Beverage – Danone operates in the global food and beverage sector, focusing on health-oriented products including dairy, plant-based, waters, and specialized nutrition.
Biotechnology – Through the acquisition of The Akkermansia Company, Danone is investing in biotic research, a subfield of biotechnology focused on microbial strains beneficial to human health.

Financials

Participants

Name	Role	Type	Description
Danone	Acquirer	Company	A leading global food and beverage company focused on health-oriented products, undertaking the acquisition to enhance its gut health offerings.
The Akkermansia Company	Target Company	Company	A Belgian biotics company known for its discovery and development of the Akkermansia muciniphila MucT strain, which supports gut health.